ADAG
Adagene Inc - ADR

225
Mkt Cap
$140.45M
Volume
58,162.00
52W High
$3.19
52W Low
$1.30
PE Ratio
-4.62
ADAG Fundamentals
Price
$3.10
Prev Close
$2.98
Open
$2.96
50D MA
$2.07
Beta
0.08
Avg. Volume
212,980.75
EPS (Annual)
-$0.7426
P/B
3.70
Rev/Employee
$748.23
$22.91
Loading...
Loading...
News
all
press releases
Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Expands By 283.2%
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) was the recipient of a large increase in short interest in January. As of January 30th, there was short interest totaling 62,815 shares, an...
MarketBeat·22h ago
News Placeholder
More News
News Placeholder
Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Drops By 31.1%
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) was the target of a large decrease in short interest in the month of January. As of January 15th, there was short interest totaling 16,394...
MarketBeat·12d ago
News Placeholder
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) have received an average recommendation of "Moderate Buy" from the six brokerages that are currently covering the firm...
MarketBeat·14d ago
News Placeholder
Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Rises By 48.9%
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 23,778 shares, a...
MarketBeat·27d ago
News Placeholder
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) have been assigned an average rating of "Moderate Buy" from the seven ratings firms that are covering the company, Marketbeat...
MarketBeat·1mo ago
News Placeholder
Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Declines By 36.8%
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest...
MarketBeat·2mo ago
News Placeholder
FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug
Adagene jumps 13.8% after the FDA grants Fast Track Status to muzastotug with pembrolizumab for MSS metastatic colorectal cancer.
Zacks·2mo ago
News Placeholder
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven analysts that are currently covering the company, MarketBeat.com...
MarketBeat·2mo ago
News Placeholder
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives Average Recommendation of "Moderate Buy" from Brokerages
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat reports. One research...
MarketBeat·3mo ago
News Placeholder
Adagene (NASDAQ:ADAG) Upgraded to Strong-Buy at Lifesci Capital
Lifesci Capital raised shares of Adagene to a "strong-buy" rating in a research report on Friday...
MarketBeat·3mo ago
<
1
2
...
>

Latest ADAG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.